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1   Introduction
The mammalian immune system is a very complex defense system against diseases. Not 
only can it protect an organism from pathogens, but also against emerging benign [CZW+05] 
and even malignant tumor cells [AFD+97]. The ability to identify a biochemical structure's 
origin is crucial for the function of this powerful, intricate system: it should fight infectious 
agents  coming  from outside  the  body,  while  the  organism's  own  healthy  cells  must  not
be attacked.
In some cases the discrimination of the immune system between self and foreign does not 
work properly, which leads to an immune response against constituent parts of the organism. 
This  can  be  a  cause  for  chronical  diseases,  some of  which  are  even  widespread,  e.g. 
diabetes mellitus type I [Bac94] and Hashimoto's thyroiditis [PFB03], but it may also happen 
in the development of cancer [ABE+01].
At  least  in the case of  cancer the immune system plays  a paradoxical  role:  it  fights the 
disease, or causes additional complications, like e.g. autoimmunity [DEC06, ETK09].
From this  it  follows  that  the  understanding  of  the  immune system  and  in  particular  the 
knowledge of the etiology of autoimmunity is a key to the development of better therapies 
and more effective drugs for certain illnesses. These prospects may be one of the reasons 
why in recent years the adaptive immune system attracted the attention of bioinformaticians 
at a progressive rate [KLY06].
Many scientists are interested in this field of research, and so are we.
We want to investigate the role that peptide folding stability plays in peptide immunogenicity. 
Our approach is based on previous work suggesting a direct relationship between a peptide's 
stability and its ability to induce an immune response.
Our  goal  is  the  development  of  a  plausible  energy  function  modeling  protein  fragment 
stability using a force field. The resulting model needs to undergo evaluation, therefore we 
use a reference dataset.  Additionally,  we want  to make an implementation of  this model 
available to the public via a webserver.
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1.1   Previous Work
The humoral immune system includes the processes of  antibody production and antigen 
recognition (antigen = antibody generator). These processes are integral parts of the humoral 
immune response both mainly performed by B lymphocytes, also known as B cells.
Research of Camacho  et al. focused on the question why and how peptides are able to 
induce  an  immune response  [CKA08].  This  property  of  immunogenicity depends  on  the 
presence of recognizable epitopes on the surface of a molecule.
The conventional paradigm of humoral immunity claims that a molecule needs a determined 
three-dimensional structure to be recognized by B cells. Peptides, being protein fragments 
consisting of a few residues only, hardly bear any stable folding. However, literature provides 
evidence that some peptides not only are recognizable antigens to B cells, but also lead to 
the  production  of  antibodies  against  corresponding  regions  of  the  original  protein
[MBP03, RVT06].
Camacho  et al. claim the dependency of peptide immunogenicity on the degree of spatial 
stability. They state that peptides can be divided into three categories depending on their free 
folding energy ∆G: (1) immune system contacts with instable fragments (∆G > 8 kcal/mol) are 
not  followed  by any response.  (2)  Weakly  stable  peptides  (∆G > 0 kcal/mol)  lead to an 
immune response against their own kind, while (3) relatively stable protein fragments with
∆G < 0 kcal/mol induce antibody production against  the fragment itself,  and also against 
peptide-like motifs in corresponding proteins.
The latter kind is the class of peptide we are especially interested in.
While the above results are interesting and raise hope of being the answer to the question 
what  the  cause  of  peptide  immunogenicity  is,  the  methods  and  dataset  underlying  the 
findings are afflicted with some shortcomings.
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Stability can be measured in different units and its computation can be based on several 
factors.  Camacho  et al. chose to solely base their  conclusions on the root mean square 
deviation  (RMSD)  of  superimposed  snapshots  of  molecular  dynamics  simulations  (MD 
simulations).  While MD simulations provide some insight  into the  stability  of  higher  order 
structures of a protein fragment, the resulting RMSD values (unit: Ångström)  are not directly 
related  to  the  ∆G  values  (unit:  kcal/mol)  used  for  the  above  described  classification. 
Moreover,  this  method  is  rather  time-consuming  and  thus  not  recommendable  for  a 
widespread use.
These problems could be solved by instead using a criterion with a more direct relation to 
stability that is additionally faster to compute.
The dataset used in Camacho et al.'s examination consists of 10 fragments made up of 18 
residues, all derived from one single protein: murine histidyl-tRNA synthetase (HRS). This 
protein  as  a  model  for  peptide  immunogenicity  is  a  good  choice.  HRS is  known  to  be 
involved in the pathogenesis of idiopathic inflammatory myopathy and the anti-synthetase 
syndrome where it plays a role as an autoantigen [YK02].
The dataset should be broadened in order to obtain results with a high degree of reliability.
3
1.2   Task
It was the aim of this thesis to implement a stability criterion based on energy computations 
using a force field, and to test the implementation with a large dataset.
Our stability criterion is based on computations with the force field AMBER (Assisted Model 
Building  and  Energy  Refinement),  which  has  been  developed  especially  for  molecular 
dynamics of biomolecules. We use it to compute the energy of a protein fragment with the 
original coordinates from the respective Potein Data Bank (PDB) file. Instead of simulating 
the dynamics of a fragment, we compute the energy resulting from its interactions with itself 
(„self-energy“) and the energy resulting from its interactions with the rest of the protein. The 
difference between these two terms („energy difference“) allows a conclusion to be drawn 
about the stability of a peptide with the same amino acid sequence as the fragment. In this 
way we approximate the peptide's free folding energy.
The dataset is being broadened by including a reference dataset of non-homologous protein 
domains [TQS+05]. We look at every potentially immunogenic fragment by sliding a window 
over  the  protein  sequence,  instead  of  picking  only  some  fragments.  Additionally  our 
computation  considers  multiple  window  lengths,  reaching  from  8  to  22  residues.  These 
lengths are in accordance with the minimum and maximum length of possible epitopes, since 
they must fit into the binding pocket of major histocompatibility complex (MHC) molecules.
These steps result in an enlargement of the dataset by a factor of about 10,000.
Furthermore we  want  to  investigate  how the  energies  correlate  with  a  peptide's  solvent 
accessible  surface (SAS) area [LR71,  SR73],  and with  its secondary structure elements. 
Thus, we implemented computations of these characteristics. This supplement allows for a 
better understanding of the dependency of a fragment's energy on its other specific features.
Beyond these improvements and extensions we provide a software for a webserver where 
interested  parties  can  analyze  user-defined  proteins  with  respect  to  their
immunogenic properties.
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2   Biological Background
2.1   Immune System
There are two ways of classifying the constituents of the immune system:
1. Innate immunity or adaptive immunity
2. Surface barriers, cellular components, or humoral components
Innate Immunity Adaptive Immunity
Surface Barriers Mechanical barriers, e.g. skin -
Cellular Components Phagocytosis Antigen recognition
Humoral Components Complement system Antibody production
Table 1: Classification of instances of the mammalian immune system
The  question  we  deal  with  in  this  thesis  concerns  the 
humoral immune response and therefore belongs into the 
context of adaptive immunity. It includes cellular (B cells), 
as well as humoral components (antibodies).
2.1.1   Antibodies
Antibodies,  also known as immunoglobulins, are proteins 
created  for  antigen  recognition.  They  consist  of  two 
identical  heavy,  and two identical light chains, connected 
by disulfide bonds, leading to a Y-like structure. The two 
tips  of  this  formation  are  hypervariable  regions:  the 
differences  in  these  antigen  binding  sites  of  different 
antibodies lead to high specificity.
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Figure 1: The light chains  
(blue, transparent) are 
shorter than the heavy ones  
(blue, opaque).
Source: Wikimedia  
Commons
2.1.2   B Cells
B cells evolve from lymphocytes. While antibody assembly is one of their main tasks and the 
function of interest in our context, they also act as antigen-presenting cells (APCs) and may 
differentiate further into memory B cells when triggered by the respective signals.
The surface of B cells is covered with B cell receptors (BCRs). They have the same overall 
structure as antibodies, hence these cells' ability to bind specific antigens.
B cell activation, a necessary step in the differentiation of lymphocytes to B cells, requires 
certain signals. There are two ways how this process can take place:
During T cell-dependent B cell 
activation a B cell binds a free antigen 
(antibody generator) or an antigen 
presented by an APC, like e.g. a 
macrophage. When the pathogen 
cross-links BCRs, the B cell ingests and 
digests it. The resulting antigen 
fragments form a complex with major 
histocompatibility complex (MHC) 
proteins from inside the B cell on the 
surface of the cell membrane. Specific 
T helper cells recognize the antigen-
MHC-complex.
Finally  it  comes to a direct  interaction 
between the two cells. The T cell releases effector molecules (cytokines), whereupon the B 
cell starts proliferation and terminal differentiation into a plasma cell. [JTW+01, Par93]
6
Figure 2: A T cell (left), B cell (right), and several  
molecules interact during T cell-dependent B cell  
activation.
Source: Wikimedia Commons
Some antigens, especially carbohydrates, activate their cognate B cells without additional 
help from T cells required, which implicates T cell-independent B cell activation. The antigen, 
which may also be presented by an APC, binds to a particular kind of BCRs, namely IgM 
antigen receptors, and causes cross-linking. This is sufficient for activating the B cell. [HR09]
2.1.3   Epitopes
An epitope, or  antigenic determinant, is 
the discriminatory surface structure of a 
macromolecule  that  leads  to  the 
recognition by the immune system.
In the majority of cases the epitopes of a 
protein  consist  of  discontinuous  amino 
acids  coming  together  in  three-
dimensional  conformation.  These  so-
called  conformational epitopes  are 
inevitably  broken  down  upon
protein denaturation.
However, this thesis does not deal with conformational epitopes, but with linear ones only. 
They consist of about 8 to 22 consecutive residues and thus even occur in peptides.
Epitope length  is  limited  by the spatial 
prerequisites  of  MHC  binding  pockets. 
MHC class I molecules allow for a length 
of 8 to 10 residues, while MHC class II 
molecules  present  peptides  of  up  to 
about  22  residues  in  length.  These 
constraints  must  be  considered  when 
examining  potential  antigens  from 
protein  fragments and it  is  reflected in 
our choice of examined window lengths.
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Figure 4: Consecutive residues of HRS form a 
fictional linear epitope (yellow).
Figure 3: Sequence-wise separated parts of HRS 
form a fictional conformational epitope (yellow).
2.2   Humoral Immune Response
The humoral immune response (lat. humor = liquid) takes place in the body fluids blood and 
lymph. It is the process of antibody production by B cells.
We describe the course of an immune response.
 
First  of  all  the involved activated B cell  recognizes its 
specific antigen, usually a non-self molecule, that is an 
intruder  like  e.g.  a  bacterium,  by  binding  it  with  its 
membrane-bound  antibodies,  the  BCRs.  This  step  is 
called antigen-recognition.
The  recognition  induces  a  complicated  maturation 
process:  the  B  cell's  terminal  differentiation  into  a 
plasma cell.
The resulting cell starts the production of large volumes 
of  antibodies  against  the  antigen  that  triggered  the 
immune  response.  The  immunoglobulins  are  being 
secreted into the body fluids.
Now it comes to an antigen-antibody reaction.
Since each antibody can bind two antigens and some antigens have more than one epitope 
on  their  surface,  a  so-called  immune  complex is  being  formed,  consisting  of  several 
antibodies and antigens. Binding the antigen implicates its immunization.
In the final  step of  the immune response the immune complex prepares the antigen for 
degradation.  This  process  can  be  realized  through  phagocytosis  or  by  the  complement 
cascade, for instance.
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Figure 5: Plasma cells are the  
result of terminal  
differentiation of B cells. The 
process usually takes place in  
lymph nodes.
Source: Wikimedia Commons
2.3   Immunogenicity
The  immunogenicity  of  a  protein  depends  on  its  unique  folding  because  the  antigen-
presentation, which is a precondition for the antigen-recognition by B cells, is controlled by 
the folding stability [TMD+04]. When the protein gets denatured, most of its epitopes will get 
lost because they lose their stable conformation. Thus, antigen-stability is possibly one of the 
crucial points of immunogenicity.
This leads to the question why few peptides, though lacking a noteworthy stability, not only 
lead  to  antibody  production  against  their  own  structure,  but  even  induce  an  immune 
response against motifs similar to the peptide, which occur in proteins.
The  answer  suggested  by  Camacho  et  al. proposes  a  dependency  of  a  peptide's 
immunogenicity on its stability, however marginal.
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Figure 6: According to Camacho et al. a peptide with minimal  
stability induces antibody production against the corresponding part  
of the cognate protein.
When a peptide leads to the production of antibodies even recognizing the corresponding 
structure in the native protein, this part of the protein is likely to be comparatively stable.
In  order  to  estimate  the  immunogenicity  of  a  peptide  we  compute  the  stability  of  the 
corresponding residues in the full protein.
In this way we make sure that the calculation is based on a reasonable start conformation: 
peptides are often protein fragments resulting from cleavage by a protease. Hence, it can be 
assumed that the start conformation of the peptide is about the same as the conformation of 
the corresponding protein residues.
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3   Implementation
In  the  following  we  describe  with  which  software  and  how exactly  we  implemented  the 
program structure.
3.1   Choice of Software
For the implementation of fragment energy, SAS area, and secondary structure computation 
we chose to use a C++ application framework. The Biochemical Algorithms Library BALL 
[BKL99,  Koh01]  provides classes and methods for  the import  and export  of  PDB files,  it 
supports the analysis and comparison of protein features, and it implements several force 
fields, e.g. AMBER, including methods for solvation [SRD08].
3.2   Program Flow
3.2.1   Protein Preparation
First, we explain the expected command line arguments and the file import.
The C++ program is given the path to a PDB file, a name for the output folder, and a range of 
window lengths. The range is specified by the minimum and maximum window length to 
compute. With regard to the capacity of  MHC molecules'  binding sites we recommend a 
standard minimum length of 8, and a standard maximum length of 22 residues.
The  program  imports  the  PDB  file  and  reads  it  into  a  system,  the  corresponding
data structure.
In a second step, the program applies a special treatment on chains and ligands.
Many proteins consist  of more than one chain. In this step the protein is split  up into its 
chains, each of which is treated as a system itself in the following iteration.
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We are not interested in ligands which are part of a PDB file, so we delete them. If a chain 
does not contain anything but a ligand, it will be empty after the deletion. We do not consider 
it any further, for that reason we just jump to the next chain.
The final preparation step deals with atom names and hydrogen atoms.
Atom names from PDB files sometimes need normalization. The correct names are being 
retrieved from entries of a fragment database.
These entries also allow for adding missing hydrogen atoms. PDB files come without them 
since the methods used for protein structure determination are not sensitive enough to detect 
these smallest atoms.
Subsequently the missing bonds between the new atoms and the protein are being added.
After  having  checked  the  consistency  of  our  model,  we  optimize  the  hydrogen  atom 
positions:  an  AMBER  force  field  is  being  set  up  and  we  perform  50  steps  of  energy 
optimization using a conjugate gradient minimizer. The changes of the atom positions lead to 
a decrease in the model's energy. After about 50 steps, the energy finally converges. We 
assume that our model now matches the natural folding of the protein to a sufficient degree.
3.2.2   Fragmentation
We run our range of window lengths over the chain's residues in three nested loops. 
 
 
    INPUT
    - 1 protein with 2 chains: 1st chain with 5 residues, 2nd chain with 7 residues
    - Window lengths: 3 - 4
    OUTPUT
       - 1st chain's fragments: +++--, -+++-, --+++, ++++-, -++++
    - 2nd chain's fragments: +++----, -+++---, --+++--, ---+++-, ----+++, ++++---, -++++--, 
                              --++++-, ---++++
Example 1: The command line parameters ./programname ./X.pdb x 3 5 result in the output  
directory x with two subdirectories x_1, x_2, each including 3 files data3.txt, data4.txt, and data5.txt.  
They contain the results of the computation for the respective fragment length. The selected residues  
are marked by a „+“, the discarded ones by a „-“.
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3.2.3   SAS Area Computation
The SAS area of the fragments is important with regard to their potential immunogenicity: if a 
fragment has a very small SAS area, it is buried and hence cannot serve as an epitope in the 
full protein. If it is mostly solvent exposed, it may constitute an epitope.
Water molecules are not part of a protein, but they have significant influence on a chain's 
spatial  conformation.  They  are  part  of  PDB  files,  however,  they  are  unwanted  in  our 
computation because they have no biological relevance in this context. Therefore we delete 
the water after the optimization of the hydrogen atoms and prior to the energy computation.
Before we fragment the chain, we assign the according atom radii to all atoms. Computing 
and storing the SAS area of each atom is done in just one more step. We add up the SAS 
areas of all atoms of a fragment in the inner nested loop.
3.2.4   Secondary Structure Assignment
The secondary structure is of interest in this context, because we want to evaluate whether 
there is a relation between particular secondary structures prevailing in a fragment and the 
fragment's energy.  If  a  secondary or  supersecondary structure like e.g.  helix/turn/helix  is 
associated with low fragment energy, it may be associated with peptide immunogenicity, too. 
Each residue is assigned a secondary structure prior  to fragmentation.  Afterwards in the 
nested loop we put together a string holding the fragment's secondary structure. This string 
equates to the final secondary structure output.
Secondary Structure: Helix Coil Turn Strand Unknown
Letter: H C T S U
Table 2: A fragment's secondary structure is described by a string consisting of the letters H, C, T, S,  
and U. Usually only the letters H, C, and S occur. A fictional fragment with 6 residues might for  
example result in the describing string „SCCCHH“.
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3.2.5   Energy Computation
We use the force field AMBER for our energy computations.
  E total = E bonded + E nonbonded
  E bonded = E bonds + E angles + E torsions
  E nonbonded = E electrostatic + E van der Waals
Table 3: AMBER sums terms representing bonds,  
angles, torsions, electrostatic interactions, and van der 
Waals forces.
It brings together bonded terms relating to covalently bonded atoms with nonbonded terms 
describing long-range interactions, like electrostatic and van der Waals forces [PC03].
    (1)
       (2)
    (3)
    (4)
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The bonded AMBER term is the sum of the equations (1), (2), and (3).
Equation (1) descrices the forces between covalently bonded atoms by a harmonic potential. 
Equation (2) sums over the energies resulting from the geometry of electron orbitals involved 
in covalent  bonding.  Twisting a bond due to bond order and neighbouring bonds or lone 
electron pairs is represented by equation (3).
Equation (4) shows which computations the nonbonded AMBER term arises from: a double 
summations over i and j takes all atom pairs into account. The first term of the summation 
represents the electrostatic interactions, the second one stands for the van der Waals forces.
In our implementation the energy computation for a fragment starts when all of its residues 
have been selected. We set up a force field on this selection and calculate its total energy. 
The resulting value is the self-energy, i.e. the sum of all energies resulting from the fragment 
atoms' interactions with other fragment atoms. Interactions with and of the protein's outlying 
residues are excluded. Finally we remove the selection.
Additionally, we want to know the energies of the fragment's interactions with the rest of the 
protein. We need a new force field, however this time we set it  up on the whole protein. 
Afterwards we select the same window as before. Then we calculate the total energy of the 
window's interactions with itself and the other protein residues („full energy“).
The difference of the energy we computed in the previous step and the self-energy is a term 
we are  strongly  interested in.  This  energy difference stands for  an  energy term itself:  it 
includes solely the interactions between the fragment atoms and the atoms outside of the 
examined window. So it describes how stable the fragment would be, if it was not part of the 
protein. The more the fragment gets stabilized by interactions with the residual protein, the 
less stable it would be in isolation, and vice versa. This formula quantifies the interrelations:
E difference = E full - E self
If  the  self-energy  is  rather  low  and  much  lower  than  the  full  energy,  the  fragment's 
corresponding peptide is probably relatively stable. The computed value does not equal the 
folding free energy ∆G, but it is an approximation, and this is what we aimed at developing.
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3.3   Webserver
We  set  up  a  webserver  for  the  analysis  of  proteins  with  regard  to  their  fragments'
potential immunogenicity.
The interface first allows the user to retrieve a PDB file directly from the RCSB Protein Data 
Bank by entering a PDB identifier, or to upload a file from his computer. 
A minimum and maximum window length has to be chosen, the preselection being 8 or 22
residues, respectively.
After  importing  the  file,  it  is  being  processed  by  the  C++ program described  in  chapter
3 Implementation.
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Figure 7: The tabs allow the user to choose between file import from the PDB and file upload 
from his computer.
Figure 8: A progress bar indicates the status of the computation. In this example the 
C++ program has completed about 18% of the analysis for the PDB file 2KMA.
After the processing is completed, our server provides the results for each protein chain. The 
user is being offered a choice of evaluations.
The available options are:
1. Secondary structure: Absolute frequencies
2. Secondary structure: Relative frequencies I
3. Secondary structure: Relative frequencies II
4. Secondary structure: High energy difference
5. Solvent accessible surface area
Examples explain their  meaning („Toggle examples“).  Each analysis  offers two download 
options: the results can be exported for printing in Portable Document Format (PDF) or for 
direct  data access in  Extensible  Markup  Language  (XML).  Exporting  to XML makes the
re-use of analysis results in other software applications especially easy.
Additionally  the  user  interface  features  a  visualization  of  the  complete  protein  structure 
imported from the PDB.
Interactive charts for each window length visualize the fragments'  self-energy and energy 
difference function, SAS area, and secondary structure distribution. If the user wants to save 
the chart to his computer, he can do so by clicking the button „Convert to image“. Thereupon 
the  interactive  chart  is  being  replaced  by  a  graphic  image,  which  can  be  saved  for
later usage.
The service will be made available to the public.
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Figure 9: The drop-down menu makes the implemented analyses available to the user. In 
this example the user chose an analysis based on the relative frequencies of secondary 
structure elements compared to the fragments' energy difference.
4   Results and Discussion
4.1   General Properties of our Model
First we wanted to know whether our program's results were comparable to Camacho et al.'s 
results, so we let it compute the energy values for HRS. To obtain useful results, we based 
our analysis on the model also used by Camacho.
Not only did we examine HRS, but the self-energy of many other proteins, too. In order to 
achieve relevant results, we evaluated the non-homologous protein domains from the Nh3D 
3.0 reference dataset. We deleted particular proteins by hand, so that the remaining dataset 
guarantees that no pairwise sequence identities after global alignment are greater than 30%.
All validation results show an elementary amount of similarity in certain aspects.
Also there are some potential error sources in our energy model. We will  discuss them in
this chapter.
4.1.1   Energy and RMSD
First  of  all  we  compared our results  with  the findings  of  Camacho  et  al. in  a line  chart. 
Unfortunately,  Camacho examined only 10 HRS fragments. This is a very small set for a 
meaningful comparison.
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Upon  visual  inspection,  the  curves'  progressions  between  the  6  fragments  411-428  to
461-478 show a rather strong correlation, while for the 3 remaining fragments there is not 
such an obvious relationship between self-energy and RMSD.
Our energy computation is only a model – a fact that applies to the RMSD calculation as 
well.  Therefore neither our results really describe the proteins in their natural way, nor do 
those of Camacho et al.
We analyzed proteins with our model,  later  on we will  let  them undergo laboratory tests 
uncovering their real immunogenicity. Unlike this chapter's comparison, this is a reliable way 
to check the biological significance of our model's results.
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Figure 10: The chart makes comparable the self-energy (red) to the RMSD values (blue).
4.1.2   Energy and Secondary Structure
We  are  interested  in  the  interrelation  between  the  energy  functions  and  a  fragment's 
secondary structure. The results show a correlation between self-energy and helix. Since the 
self-energy  and  the  energy  difference  are  correlated  negatively,  there  is  a  negative 
correlation between energy difference and helix, too. For strand and coil it is just the other 
way around.
However,  we do not  conclude that  helices are energetically  unfavorable,  since a helix is 
known to be a common secondary structure with  low energy resulting from its hydrogen 
bonds. Helix is expected to be the structure with the highst stability, because our fragments 
include its stabilizing hydrogen bonds, while the bonds stabilizing a beta strand often come 
from a second parallel or antiparallel strand.
We assume that the surprising results may be caused by a weakness of our model.  We 
discuss this possibility in chapter 4.1.5 Shortcomings of our Model.
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Figure 11: Self-energy (orange) correlates with the curve indicating helices (green), while it  
correlates negatively with the energy difference (red) in this example of HRS fragments with 
11 residues.
Beyond  that  we  studied  the  occurence  of  the  supersecondary  structures  hairpin 
(strand/coil/strand) and helix/coil/helix. Our definition requires that a hairpin consist of at least 
two residues in strand structure followed by at least one residue in coil structure followed 
again  by  at  least  two  residues  in  strand  structure.  The  same  scheme  applies
to helix/coil/helix.
This  tabular  analysis  provides  insight  into  the  distribution  of  secondary  structures  over 
fragments with high energy difference. The consequence of helices being associated with 
energy  difference  levels  is  that  helix/coil/helix  hardly  occurs  in  those  fragments.  Hairpin 
seems to be a more common structure in this kind of fragments.
However, the significance of these numbers depends on the quality of our model and are 
influenced by the afore mentioned shortcomings.
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Table 4: The expected value for the occurence of any structure in fragments with low self-energy is 
33.33%. While helix/coil/helix tends to occur in fragments with high self-energy, hairpin often is  
found in those with low self-energy.
Table 12: The expected value for the occurence of any structure in fragments with hihg 
energy difference is 33.33%. While helix/coil/helix tends to occur in fragments with low 
energy difference, hairpin often is found in those with high energy difference.
4.1.3   Energy and SAS Area
An  epitope  must  lie  on  the  surface  of  its  molecule  in  order  to  be  able  to  interact  with 
antibodies.  Thus,  a  particularly  small  SAS  area  is  a  knock-out  criterion  for  fragment 
immunogenicitiy in this context.
Aside from this consideration, the SAS area of a fragment also reveals a minor interrelation 
with fragment energy.
Folded proteins usually have a hydrophobic core in which side chain packing stabilizes the 
folded state, and charged or polar side chains occupy the surface where they interact with 
surrounding water. Thus, the self-energy terms should correlate at least weakly negatively 
with the SAS area, which is what  they actually do – with the exception of small proteins 
where nearly no fragments are buried.
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Figure 13: The self-energy (red) and SAS area curve (blue) show a weak negative correlation.
4.1.4   Smoothness
When comparing the charts for two protein fragments with different window lengths, it can be 
seen that longer fragments yield more smooth curves. When computing longer fragments, 
the overlap of two consecutive fragments increases, too. Thus, the influence of the variable 
residue's self-energy, SAS area, and secondary structure terms on the fragment's properties 
is smaller the more identical residues two fragments have.
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Figure 13: 1OAI curves for different window lengths demonstrate the increase in smoothness.
Figure 14: 1OAI, randomly picked from the reference dataset, shows the curves' smoothing.
4.1.5   Shortcomings of our Model
Some aspects of protein structure are not fully taken into account by our model.
The amino acid cystein has a thiol side chain, which often is involved in disulfide bonds. 
These covalent bonds stabilize proteins' tertiary and quarternary structures, but our model 
does not provide a special handling for them.
The same applies for ligands. We delete them prior to the energy computation, but they also 
contribute to the overall protein energy and stability.
Also, we do not pay full attention to the fact that the two amino acids at the ends of the 
fragment in most cases are covalently bonded to outlying residues. Maybe it is necessary to 
break  these  bonds  prior  to  the  energy  computation.  Breaking  the  peptide  bonds  would 
require an additional treatment of the N-terminal and C-terminal ends of the fragment. Adding 
caps (-H, respectively -OH) could solve this problem.
Finally, the high energy values for helices could be a result of unsufficient hydrogen atom 
position optimization. Splitting up the self-energy term revealed that the high energy level is a 
result  of  extraordinarily  strong electrostatic  interactions  in  fragments with  helices.  This is 
probably a weakness of our model.
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4.2   Protein Analyses
Though we examined many proteins in order to obtain a broad dataset for evaluation, we 
were particularly interested in the findings about some of them. Besides HRS we took a 
closer look at  Enolase I  (ENO1).  It  will  later  be subject  to laboratory examinations since 
matching monoclonal antibodies are available.
4.2.1   HRS
HRS is  a medium sized protein consisting  of  one chain  only.  Since it  is  known to have 
implications as an autoantigen, it is an interesting subject of study.
Our  evaluations  show the curves'  increasing  smoothness,  the  longer  the  fragments  are. 
There is a slight negative correlation between self-energy and SAS area.
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Figure 15: The chart for HRS shows all typical characteristics of our model.
With  regard  to  biological  sampling  we  recommend  fragments  with  certain  properties:
not too small SAS area, low self-energy and higher energy difference. In the case of HRS we 
picked out the fragments between residue 138 and 147, as well as those between 463 and 
498. Window length does not apply here, since fragments with varying residue count should 
be subject to examination.
These  recommendations  should  be  taken  with  reserve  since  they  are  based  on  results 
possibly biased by wrong helix energies.
4.2.2   ENO1
The human lyase enolase 1 alpha consists of 4 chains, out of which only one is sequence-
unique: chain A. The PDB file comes with two ligands included. One of them is not being 
deleted successfully by our C++ program, since in this case the PDB file was not standards-
compliant. Therefore we deleted it by hand.
Our charts reveal that there is little difference between chain A and the other chains. 
Because of  the very long runtime required for  the energy difference computation  of  this 
relatively large protein, we only evaluated its self-energy.
The curves of helix and self-energy correlate negatively, as they did in the case of HRS, and 
so do self-energy and SAS area curve,  but  in  a less obvious  manner.  The smoothness 
increases when chosing larger fragment visualizations.
The fragments recommended for further immunological investigations can be found between 
residues 33 and 70, as well as between 248 and 286.
These recommendations should be taken with reserve, too.
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Figure 16: Although ENO1's chain A (2PSN_1) and chain B (2PSN_2, see above) have slightly  
different sequences, their overall appearance is rather similar.
5   Conclusion and Outlook
This thesis focuses on the development of an energy model linked to peptide stability.
In  the  previous  chapters  we  introduced  the  fundamental  concepts  of  folding  stability, 
immunogenicity,  and  the  interrelation  of  both.  We  presented  the  implementation  and 
validation of our suggested model, which is based on the stability of corresponding protein 
fragments. The explanation of the validation's results exposed the potential, as well as the 
inherent difficulties of our approach.
There are many ways how the output of this thesis can still be improved, extended, and used 
further in the future.
The C++ program itself can perhaps be sped up by optimizing the code.
The implementation of the energy model could by modified in order to yield more realistic 
results, especially for helices.
Furthermore it is possible to take implicit solvation by the surrounding medium into account in 
our model, and maybe to even carry out free energy perturbation (FEP) calculations.
In order to find a better  start  conformation for  the fragments one could also sample the 
energy space, e.g. with a simulated annealing algorithm.
The webserver could be improved by letting a database do the data and user management. 
The  currently  implemented  method,  which  is  based  on  text  files,  is  rather  simplistic.  A 
molecular visualization with a colouring according to fragment energy could be integrated 
using BALLView, a molecular modeling and visualization application [MHL+05].
Previous to carrying out laboratory tests with the afore mentioned fragments, they could be 
synthesized and analyzed via nuclear magnetic resonance (NMR) spectroscopy in order to 
gain physical data about the stability of the molecules. The NMR spectroscopy technique 
offers the possibility to reveal the structure of solute molecules. Depending on the results' 
degree of resolution one can make conclusions about the stability of the peptide. A high 
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resolution is an indicator for high stability. Peptides leading to a low resolution need not be 
subject to further tests.
The actual immunogenicity of eligible candidates could be tested with tissues and/or model 
organisms, e.g. mice (Mus musculus) or rats (Rattus norvegicus).
In  this  context  it  would  be  interesting  to  take  a  closer  look  at  peptides  with  mutations. 
Changes in the peptide sequence can change the molecule's stability. One could investigate 
which mutations increase stability and are known autoimmunogens, too. A starting point for 
searching mutations involved in a disease is the Roche Cancer Genome Database (RCGDB) 
[KEL+10]. This data pool has been released recently and is freely available online.
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Table of Abbreviations
AMBER Assisted Model Building with Energy Refinement
APC Antigen-presenting cell
BALL Biochemical Algorithms Library
BCR B cell receptor
ENO1 Enolase 1 alpha
FEP Free energy perturbation
HRS Histidyl-tRNA synthetase
MD Molecular dynamics
MHC Major histocompatibility complex
NMR Nuclear magnetic resonance
PDB Protein Data Bank
PDF Portable Document Format
RCGDB Roche Cancer Genome Database
RMSD Root mean square deviation
SAS Solvent accessible surface
XML Extensible Markup Language
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